New York, NY, United States of America

Fadi El Salem

This inventor holds 1 USPTO granted patent. Top assignee: Icahn School of Medicine at Mount Sinai. Active years: 2026.


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fadi El Salem: Innovator in Kidney Transplant Technology

Introduction

Fadi El Salem is a notable inventor based in New York, NY (US). He has made significant contributions to the field of medical technology, particularly in the area of kidney transplantation. His innovative work focuses on improving the outcomes of kidney grafts through advanced imaging and deep learning techniques.

Latest Patents

Fadi El Salem holds a patent for a deep learning approach that identifies pathological abnormalities predictive of graft loss in kidney transplants. The patent, titled "Systems and methods for identifying risk of kidney graft failure," outlines a method where an image of a graft biopsy is obtained. This image represents various morphological classes, including tissue compartments and inflammation classes. The image is then inputted into a trained model that identifies corresponding objects within the image for each morphological class. Digital features are generated for each class, which are compared to a reference criterion to determine the risk of kidney graft failure. This innovative approach has the potential to significantly enhance patient outcomes in kidney transplantation.

Career Highlights

Fadi El Salem is affiliated with the Icahn School of Medicine at Mount Sinai, where he applies his expertise in medical imaging and machine learning. His work at this prestigious institution allows him to collaborate with leading researchers and contribute to groundbreaking advancements in healthcare technology.

Collaborations

[This section has been skipped due to space constraints.]

Conclusion

Fadi El Salem's contributions to the field of kidney transplantation through his innovative patent demonstrate the importance of integrating technology with medicine. His work not only enhances the understanding of graft failure risks but also paves the way for improved patient care in the future.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…